Pharmaceutical - Markets & Marketing, USA

Filter

Current filters:

Markets & MarketingUSA

Popular Filters

1 to 25 of 87 results

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

12-02-2015

Anglo-Swedish pharma major AstraZeneca has agreed to pay the US government $7.9 million to settle allegations…

AstraZenecaCardio-vascularGastro-intestinalsLegalMarkets & MarketingNexiumPharmaceuticalPlendilPrilosecToprol XLUSA

Zubsolv market share boosts Orexo valuation, according to Edison research

Zubsolv market share boosts Orexo valuation, according to Edison research

10-02-2015

Swedish drug developer Orexo has laid the foundations to accelerate growth of its Zubsolv (buprenorphine…

FinancialMarkets & MarketingNeurologicalOrexoPharmaceuticalSwedenUSAZubsolv

Revised FDA Draft Guidance for consumer-directed promotional Rx drug labeling

Revised FDA Draft Guidance for consumer-directed promotional Rx drug labeling

09-02-2015

The US Food and Drug administration has released revised draft guidance for industry, “Brief Summary…

Markets & MarketingPharmaceuticalRegulationUSA

Sanofi and MannKind's Afrezza now available in the USA

Sanofi and MannKind's Afrezza now available in the USA

03-02-2015

The only inhaled insulin Afrezza (human insulin) Inhalation Powder, developed by French drug major Sanofi…

AfrezzaDiabetesMannKindMarkets & MarketingPharmaceuticalSanofiUSA

Sparse pipeline for acromegaly and gigantism treatment limiting market growth

03-02-2015

The acromegaly and gigantism treatment market will expand at a modest compound annual growth rate (CAGR)…

EuropeMarkets & MarketingMetabolicsNovartisPfizerPharmaceuticalSandostatin LARSigniforSomavertUSA

Rapid expansion forecast for global Cushing’s syndrome drug market

Rapid expansion forecast for global Cushing’s syndrome drug market

29-01-2015

The global Cushing’s syndrome (CS) treatment market will expand rapidly in value from around $179 million…

CortendoEuropeHRA PharmaKetoconazoleMarkets & MarketingMetabolicsNormoCortNovartisPharmaceuticalRare diseasesSigniforUSA

Merck & Co drops marketing of hepatitis C drug Victrelis in USA

Merck & Co drops marketing of hepatitis C drug Victrelis in USA

22-01-2015

In an open letter to pharmacy professions, US pharma giant Merck & Co has advised that it is voluntarily…

Anti-viralsMarkets & MarketingMerck & CoPharmaceuticalUSAVictrelis

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

13-01-2015

The launch of novel drugs and biosimilars will drive steady growth in the global rheumatoid arthritis…

AmgenAnti-Arthritics/RheumaticsEnbrelHumiraMarkets & MarketingPharmaceuticalResearchUSA

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

11-01-2015

The US subsidiary of Japanese drug major Daiichi Sankyo has agreed to pay the United States and state…

Daiichi SankyoFinancialMarkets & MarketingPharmaceuticalUSA

Tenfold growth by 2023 forecast for celiac disease drug market

Tenfold growth by 2023 forecast for celiac disease drug market

08-01-2015

The celiac disease treatment market value will expand more than tenfold from an estimated $49.6 million…

AbbVieEuropeGastro-intestinalslarazotide acetatelatiglutenaseMarkets & MarketingPharmaceuticalTeva Pharmaceutcal IndustriesUSA

USA files suit against Omnicare for accepting kickbacks from Abbott

23-12-2014

The United States has filed a civil False Claims Act complaint against Omnicare alleging that it solicited…

Abbott LaboratoriesDepakoteLegalMarkets & MarketingNeurologicalOmnicarePharmaceuticalUSA

Court tells Actavis it must continue Namenda IR distribution

Court tells Actavis it must continue Namenda IR distribution

12-12-2014

Ireland-headquartered generic drugmaker Actavis confirmed that Judge Robert Sweet of the US District…

ActavisLegalMarkets & MarketingNamendaNeurologicalPharmaceuticalUSA

Age-related macular degeneration treatment market to reach $10 billion by 2023

Age-related macular degeneration treatment market to reach $10 billion by 2023

04-12-2014

The market for treatments of age-related macular degeneration across seven major countries will almost…

AvastinEuropeEyleaFovistaLucentisMarkets & MarketingOphthalmicsPharmaceuticalUSA

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Global melanoma market set to reach $3.6 billion by 2020

12-11-2014

The global melanoma therapeutics market was valued at $1.3 billion in 2013 and will expand at a compound…

Bristol-Myers SquibbEuropeJapanKeytrudaMarkets & MarketingMerck & CoOncologyOpdivoPharmaceuticalUSAYervoy

Afaxys announces wider US availability of ella emergency contraceptive

12-11-2014

US drugmaker Afaxys Pharmaceuticals, a division of Afaxys Inc, has announced wider US availability of…

AfaxysellaHRA PharmaMarkets & MarketingPharmaceuticalReproductiveUSAWomen's Health

Biologics will complement statins in cholesterol treatment space, says GlobalData

Biologics will complement statins in cholesterol treatment space, says GlobalData

11-11-2014

Biologics will play an influential role in shaping the future of cardiovascular drug treatment, in particular…

alirocumabAmgenCardio-vascularevolocumabMarkets & MarketingPharmaceuticalRegeneronSanofiUSA

Pharming and Salix's Ruconest launches in the USA for hereditary angioedema

Pharming and Salix's Ruconest launches in the USA for hereditary angioedema

03-11-2014

Pharming Group and Salix Pharmaceuticals have launched Ruconest (C1 esterase inhibitor) in the USA for…

Cardio-vascularMarkets & MarketingPharmaceuticalPharming Group NVRuconestSalixUSA

Most-used agents in US bipolar disorder treatment sector; report

Most-used agents in US bipolar disorder treatment sector; report

24-10-2014

Through analysis of US longitudinal patient-level claims data, Bristol-Myers Squibb and Otsuka’s Abilify…

AbilifyBristol-Myers SquibbCymbaltaDainippon Sumitomo PharmaEli LillyGlaxoSmithKlineLamotrigineLatudaMarkets & MarketingNeurologicalOtsukaPharmaceuticalUSA

Orexigen earns total $100 million milestone on Contrave

Orexigen earns total $100 million milestone on Contrave

15-10-2014

US biopharma company Orexigen Therapeutics says it has earned a $70 million milestone payment from partner…

ContraveFinancialMarkets & MarketingMetabolicsOrexigen TherapeuticsPharmaceuticalTakeda PharmaceuticalUSA

1 to 25 of 87 results

COMPANY SPOTLIGHT

Menarini

Back to top